- Home
- CHEK vs HOTH Comparison
CHEK vs HOTH Comparison
Compare CHEK & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- HOTH
- Stock Information
- Founded
- CHEK 2004
- HOTH 2017
- Country
- CHEK Israel
- HOTH United States
- Employees
- CHEK N/A
- HOTH N/A
- Industry
- CHEK Medical Electronics
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- CHEK Health Care
- HOTH Health Care
- Exchange
- CHEK Nasdaq
- HOTH Nasdaq
- Market Cap
- CHEK 5.1M
- HOTH 5.8M
- IPO Year
- CHEK 2015
- HOTH 2019
- Fundamental
- Price
- CHEK $0.61
- HOTH $0.81
- Analyst Decision
- CHEK
- HOTH Strong Buy
- Analyst Count
- CHEK 0
- HOTH 4
- Target Price
- CHEK N/A
- HOTH $4.75
- AVG Volume (30 Days)
- CHEK 14.0K
- HOTH 1.2M
- Earning Date
- CHEK 02-14-2025
- HOTH 12-24-2024
- Dividend Yield
- CHEK N/A
- HOTH N/A
- EPS Growth
- CHEK N/A
- HOTH N/A
- EPS
- CHEK N/A
- HOTH N/A
- Revenue
- CHEK N/A
- HOTH N/A
- Revenue This Year
- CHEK N/A
- HOTH N/A
- Revenue Next Year
- CHEK N/A
- HOTH N/A
- P/E Ratio
- CHEK N/A
- HOTH N/A
- Revenue Growth
- CHEK N/A
- HOTH N/A
- 52 Week Low
- CHEK $0.61
- HOTH $0.58
- 52 Week High
- CHEK $3.45
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- CHEK 19.90
- HOTH 42.94
- Support Level
- CHEK $0.61
- HOTH $0.82
- Resistance Level
- CHEK $0.63
- HOTH $0.84
- Average True Range (ATR)
- CHEK 0.04
- HOTH 0.04
- MACD
- CHEK -0.00
- HOTH -0.00
- Stochastic Oscillator
- CHEK 0.00
- HOTH 14.50
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.